Celldex Therapeutics, Inc. — Director's Dealing 2016

Dec 15, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Celldex Therapeutics, Inc. (CLDX)
CIK: 0000744218
Period of Report: 2016-12-14

Reporting Person: McMahon Gerald PhD (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-12-14	Non-Qualified Stock Otion (right to buy)	$3.72	A	8000	Acquired	2026-12-14	Common Stock (8000)	Direct

Footnotes

F1: Represents option granted by the Issuer pursuant to its 2008 Stock Option and Incentive Plan.

F2: 100% of the total amount of shares subject to the Option vests on December 14, 2017.